ArticleJournal of the American Academy of Dermatology2012
Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.
Article in Journal of the American Academy of Dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- A Review of Modern Therapies and New Innovations in the Treatment of Cutaneous Graft-versus-Host Disease.Dermatology and therapy · 2026Review
- Clinical Application of an Oral Liquid Bandage (ORAPLA) for Traumatic and Surgical Oral Mucosal Wounds: A Technical Note.Dentistry journal · 2026Article
- Every Fever Not Merely Due to Antibiotic Deficiency: Chronic Graft-Versus-Host Disease Case Report.Cureus · 2024Article
- Epidermal barrier function in patients after allogeneic hematopoietic stem cell transplantation - a pilot study.Postepy dermatologii i alergologii · 2022Article
- Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.American journal of clinical dermatology · 2018Review
- The immune reconstitution of the skin following sex-mismatched allogeneic haematopoietic stem cell transplant: a prospective case series utilizing fluorescence in situ hybridization and immunohistochemistry.The British journal of dermatology · 2018Article
- Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.Journal of the American Academy of Dermatology · 2014Article
- Hyperpigmented follicular papules and bullae in an immunocompromised infant.The Journal of clinical and aesthetic dermatology · 2014Article
- A review of stem cell translation and potential confounds by cancer stem cells.Stem cells international · 2013Review
- The role of phototherapy in pediatric dermatology.Anais brasileiros de dermatologiaReview
- Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-host disease (GVHD) outlined in part I of this review. However, the complexity of the patient with GVHD, including comorbidities, potential drug interactions related to polypharmacy, and the lack of evidence-based treatment guidelines, are significant challenges to optimizing patient care. In this section, we will provide an outline for the role of the dermatologist in a multispecialty approach to caring for patients with GVHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.